felin
infecti
periton
fip
invari
fatal
diseas
cat
caus
system
infect
felin
coronaviru
fcov
term
felin
infecti
periton
viru
fipv
lethal
patholog
associ
fip
granulomat
inflamm
tcell
lymphopenia
thought
mediat
aberr
modul
immun
system
due
infect
cell
monocyt
macrophag
overproduct
proinflammatori
cytokin
occur
cat
fip
suggest
play
signific
role
diseas
process
howev
mechan
underli
process
remain
unknown
show
infect
primari
bloodderiv
felin
mononuclear
cell
fipv
wsu
lead
rapid
activ
mapk
pathway
activ
regul
product
proinflammatori
cytokin
tumor
necrosi
factor
alpha
tnfalpha
beta
beta
fipvinduc
mapk
activ
proinflammatori
cytokin
product
inhibit
pyridinyl
imidazol
inhibitor
sb
sc
dosedepend
manner
fipvinduc
mapk
activ
observ
primari
felin
bloodderiv
mononuclear
cell
individu
purifi
multipl
spf
cat
inhibit
tnfalpha
product
pyridinyl
imidazol
inhibitor
coronavirus
divers
famili
envelop
positivestrand
rna
virus
infect
wide
rang
speci
includ
human
coronavirus
divid
three
group
group
infect
mammal
group
infect
bird
perlman
et
al
felin
coronavirus
fcov
belong
group
classifi
either
serotyp
ii
depend
sequenc
spike
protein
rottier
addit
serotyp
divid
two
biotyp
design
either
felin
enter
coronaviru
fecv
felin
infecti
periton
viru
fipv
base
patholog
outcom
cat
vennema
et
al
fecv
ubiquit
amongst
felin
caus
mild
often
unappar
enter
fipv
lead
lethal
system
infect
mark
sever
granulomat
inflamm
pedersen
et
al
pedersen
et
al
weiss
scott
mechan
underli
drastic
differ
diseas
two
biotyp
remain
elus
name
fecv
fipv
isol
serotyp
virtual
indistinguish
genet
antigen
level
howev
shown
two
biotyp
possess
markedli
differ
abil
infect
cell
immun
system
fipv
isol
possess
extend
tropism
allow
infect
macrophag
monocyt
stoddart
scott
recent
studi
suggest
alter
tropism
may
due
mutat
protein
affect
protein
cleavag
fusion
activ
entri
regan
et
al
rottier
et
al
viral
pathogen
infect
immun
cell
eg
human
immunodefici
viru
hiv
dengu
viru
known
induc
aberr
cytokin
product
process
propos
play
role
patholog
outcom
respect
diseas
fantuzzi
et
al
kedzierska
crow
leong
et
al
studi
cat
fip
shown
cytokin
express
alter
compar
healthi
anim
dean
et
al
kiss
et
al
specif
note
express
proinflammatori
cytokin
tumor
necrosi
factor
alpha
tnfalpha
beta
beta
significantli
increas
cat
fip
like
produc
infect
macrophag
monocyt
kiss
et
al
takano
et
al
takano
et
al
shown
tnfalpha
abl
induc
felin
tcell
apoptosi
make
like
caus
agent
tcell
lymphopenia
fipvinfect
cat
dean
et
al
takano
et
al
addit
tnfalpha
shown
increas
express
fcov
receptor
aminopeptidas
n
apn
caus
target
cell
suscept
viral
infect
exacerb
diseas
takano
et
al
howev
despit
critic
role
patholog
outcom
fip
mechan
regul
fipvinduc
upregul
proinflammatori
cytokin
remain
undescrib
mitogenactiv
protein
kinas
mapk
famili
protein
serv
compon
signal
pathway
within
cell
order
process
respond
extracellular
stimuli
raman
et
al
typic
receptor
cell
surfac
initi
signal
cascad
lead
phosphoryl
transloc
mapk
nucleu
regul
transcript
activ
whitmarsh
recent
year
becom
clear
mapk
also
regul
process
outsid
nucleu
mrna
translat
cytoskelet
remodel
frevel
et
al
huang
et
al
three
major
mapk
pathway
identifi
conserv
eukaryot
cell
rang
yeast
mammal
pathway
design
extracellular
signalregul
kinas
cjun
ntermin
kinas
mapk
pearson
et
al
gener
erk
pathway
activ
prolif
stimuli
jnk
mapk
pathway
activ
extracellular
stress
ultraviolet
light
heat
osmot
shock
pearson
et
al
mapk
origin
identifi
target
pyridinyl
imidazol
compound
shown
inhibit
product
tnfalpha
lipopolysaccharid
lp
stimul
human
monocyt
lee
et
al
subsequ
studi
shown
mapk
pathway
respons
phosphoryl
larg
group
transcript
translat
respons
element
directli
regul
express
wide
varieti
proinflammatori
cytokin
kumar
et
al
due
involv
cytokin
regul
reason
mapk
pathway
might
play
role
increas
product
proinflammatori
cytokin
observ
cat
fip
studi
examin
activ
mapk
pathway
respons
infect
fipv
primari
felin
bloodderiv
mononuclear
cell
also
investig
role
mapk
tnfalpha
beta
product
effect
mapk
inhibitor
process
mapk
pathway
shown
activ
multipl
viral
pathogen
infect
adamson
et
al
banerje
et
al
dumitru
et
al
erhardt
et
al
holloway
coulson
zacho
et
al
determin
whether
mapk
pathway
activ
infecti
lifecycl
fipv
primari
felin
bloodderiv
mononuclear
pfbm
cell
inocul
either
moi
untreat
cell
infect
cell
rang
min
h
pi
lyse
analyz
western
blot
mapk
mab
untreat
cell
show
minim
level
mapk
phosphoryl
howev
addit
either
viru
isol
caus
rapid
phosphoryl
mapk
increas
within
min
pi
fig
c
mapk
underw
dephosphoryl
min
show
second
phase
phosphoryl
later
infect
h
pi
less
pronounc
fig
determin
whether
viral
replic
requir
fipvinduc
mapk
activ
uvinactiv
viru
ad
pfbm
cell
analyz
western
blot
describ
fig
uvtreat
fipv
also
induc
mapk
phosphoryl
howev
activ
biphas
instead
remain
sustain
throughout
h
timecours
fig
membran
reprob
mapk
pab
show
equal
amount
mapk
present
sampl
fig
b
confirm
mapk
pathway
activ
fipv
pfbm
cell
inocul
moi
fix
cell
immunofluoresc
microscopi
mapk
show
rapid
phosphoryl
min
pi
total
amount
mapk
remain
unchang
fig
addit
mapk
infect
cell
show
increas
nuclear
local
compar
untreat
cell
phenomenon
highli
associ
regul
transcript
activ
fig
data
indic
mapk
pathway
activ
infect
pfbm
cell
fipv
viral
replic
dispens
activ
occur
mapk
pathway
first
discov
investig
target
pyridinyl
imidazol
compound
block
lpsinduc
cytokin
induct
human
monocyt
lee
et
al
test
effect
pyridinyl
imidazol
inhibitor
fipvinduc
mapk
phosphoryl
pfbm
cell
treat
either
sb
sc
dmso
control
h
inocul
moi
min
pi
cell
lyse
analyz
western
blot
mapk
mab
cell
pretreat
dmso
alon
show
rapid
fipvinduc
phosphoryl
mapk
howev
pretreat
either
sb
sc
show
activ
compar
uninfect
cell
fig
data
demonstr
fipvinduc
mapk
activ
block
pyridinyl
imidazol
inhibitor
activ
mapk
pathway
shown
requir
replic
virus
includ
murin
coronaviru
mous
hepat
viru
mhv
banerje
et
al
investig
whether
activ
mapk
pathway
requir
replic
fipv
pfbm
cell
treat
either
sb
sc
dmso
control
h
inocul
h
pi
cell
fix
stain
antifipv
n
protein
mab
shown
fig
pretreat
mapk
inhibitor
signific
effect
fipv
replic
pfbm
cell
activ
mapk
viral
pathogen
shown
induc
product
proinflammatori
cytokin
tnfalpha
beta
banerje
et
al
griego
et
al
lee
et
al
lee
et
al
sloan
jerom
wang
et
al
yurochko
huang
investig
whether
tnfalpha
product
fipvinfect
pfbm
cell
regul
mapk
activ
pfbm
cell
treat
either
sb
sc
dmso
h
inocul
moi
h
pi
supernat
collect
concentr
analyz
western
blot
antitnfalpha
pab
cell
pretreat
dmso
alon
show
signific
product
tnfalpha
howev
pretreat
either
sb
sc
show
detect
product
tnfalpha
compar
uninfect
cell
fig
quantifi
product
tnfalpha
infect
perform
describ
except
h
pi
supernat
collect
analyz
antitnfalpha
captur
elisa
infect
cell
pretreat
dmso
alon
show
signific
product
tnfalpha
pgml
howev
pretreat
sb
sc
result
reduct
tnfalpha
product
respect
fig
uninfect
cell
produc
tnfalpha
detect
level
assay
data
shown
overal
data
indic
product
proinflammatori
cytokin
tnfalpha
fipvinfect
pfbm
cell
regul
activ
mapk
pathway
show
reduct
fipvinduc
tnfalpha
product
sb
sc
specif
pyridinyl
imidazol
inhibitor
pfbm
cell
treat
either
sb
sc
rang
concentr
dmso
h
inocul
moi
seen
previou
data
pfbm
cell
pretreat
dmso
alon
produc
signific
amount
tnfalpha
howev
pretreat
sb
sc
result
signific
reduct
tnfalpha
product
dosedepend
manner
fig
known
individu
anim
vari
reaction
infect
fipv
kiss
et
al
determin
whether
fipvinduc
mapk
activ
specif
singl
anim
pfbm
cell
individu
prepar
six
addit
spf
cat
pfbm
cell
individu
purifi
anim
inocul
moi
untreat
cell
infect
cell
min
pi
lyse
h
pi
supernat
collect
tnfalpha
product
quantifi
antitnfalpha
captur
elisa
b
tnfalpha
produc
untreat
cell
detect
limit
assay
pgml
fig
fipvinduc
tnfalpha
product
inhibit
dosedepend
manner
sb
sc
pfbm
cell
pretreat
either
sb
sc
rang
concentr
dmso
h
inocul
moi
h
pi
supernat
collect
tnfalpha
product
quantifi
antitnfalpha
captur
elisa
tnfalpha
untreat
cell
detect
limit
assay
pgml
analyz
western
blot
mapk
mab
consist
previou
data
untreat
cell
show
minim
level
mapk
phosphoryl
addit
fipv
caus
rapid
phosphoryl
mapk
pfbm
cell
six
cat
fig
membran
reprob
mapk
pab
show
equal
amount
mapk
present
sampl
fig
addit
regul
tnfalpha
product
mapk
analyz
pfbm
cell
six
spf
cat
pfbm
cell
anim
treat
sc
dmso
h
inocul
moi
h
pi
supernat
collect
analyz
antitnfalpha
captur
elisa
baselin
level
tnfalpha
product
differ
slightli
amongst
cat
test
treatment
inhibitor
sc
result
trend
observ
previou
experi
signific
reduct
tnfalpha
level
fig
data
taken
togeth
suggest
fipvinduc
activ
mapk
pathway
pfbm
cell
repres
common
mechan
viru
promot
tnfalpha
product
cat
cat
fip
also
report
show
increas
level
proinflammatori
cytokin
beta
investig
whether
beta
product
fipvinfect
pfbm
cell
regul
mapk
activ
pfbm
cell
treat
either
sb
sc
dmso
h
inocul
moi
h
pi
supernat
collect
analyz
beta
captur
elisa
infect
cell
pretreat
dmso
alon
show
signific
product
beta
pgml
howev
pretreat
sb
sc
result
reduct
beta
product
respect
fig
neither
infect
uninfect
pfbm
cell
produc
signific
level
fig
overal
data
indic
tnfalpha
beta
product
fipvinfect
pfbm
cell
regul
mapk
activ
situat
appli
modul
signal
pathway
virus
becom
recogn
key
pathogen
determin
viral
diseas
mediat
aberr
host
immunolog
respons
case
fip
cytokin
product
markedli
alter
anim
diseas
compar
healthi
anim
overproduct
proinflammatori
cytokin
tnfalpha
particular
indic
poor
outcom
kiss
et
al
felin
tnfalpha
caus
apoptosi
felin
tcell
implic
caus
agent
tcell
lymphopenia
upregul
fipv
receptor
apn
make
target
cell
suscept
infect
vitro
dean
et
al
kiss
et
al
takano
et
al
takano
et
al
shown
previous
fipvinfect
monocyt
upregul
express
tnfalpha
howev
mechan
regul
process
remain
undescrib
studi
show
infect
fipv
caus
rapid
activ
mapk
pathway
pfbm
cell
process
directli
regul
product
proinflammatori
cytokin
tnfalpha
beta
shown
fig
fipvinduc
mapk
activ
pfbm
cell
occur
biphas
tempor
pattern
mimic
observ
viral
pathogen
activ
mapk
pathway
infect
influenza
viru
pleschka
et
al
present
unabl
defin
mechan
fipv
particl
abl
activ
mapk
pathway
howev
rapid
natur
initi
activ
suggest
occur
earli
entri
like
due
interact
protein
receptor
model
support
observ
uvinactiv
viru
also
induc
rapid
activ
mapk
pathway
activ
markedli
differ
report
mhv
infect
cell
activ
occur
h
pi
uvtreat
viral
particl
induc
phosphoryl
mapk
banerje
et
al
notabl
fipv
receptor
apn
local
lipid
raft
navarret
santo
et
al
nomura
et
al
known
signal
portal
mapk
pathway
calzolari
et
al
head
et
al
olsson
sundler
sugawara
et
al
wang
et
al
zeidan
et
al
fact
recent
shown
rhinoviru
activ
mapk
pathway
action
lipid
raft
rhoa
dumitru
et
al
investig
necessari
determin
role
apn
lipid
raft
initi
phase
fipvinduc
mapk
activ
beta
product
interestingli
uvinactiv
fipv
induc
prolong
mapk
activ
rather
biphas
activ
induc
untreat
viral
particl
suggest
fipv
may
activ
mapk
entri
suppress
mapk
earli
phase
replic
second
phase
fipvinduc
mapk
activ
induc
untreat
viral
particl
h
pi
may
caus
product
proinflammatori
cytokin
shown
tnfalpha
activ
mapk
signal
associ
cytoplasm
domain
receptor
tnf
receptor
associ
death
domain
protein
tradd
tnf
receptorassoci
factor
carpenti
et
al
hsu
et
al
hsu
et
al
therefor
tnfalpha
produc
initi
phase
fipvinduc
mapk
activ
may
caus
latter
phase
activ
pretreat
pyridinyl
imidazol
inhibitor
sb
sc
block
product
tnfalpha
beta
suggest
mapk
directli
regul
product
cytokin
fipvinfect
pfbm
cell
upregul
product
fig
fipvinduc
tnfalpha
product
pfbm
cell
six
spf
cat
inhibit
sc
pfbm
cell
individu
prepar
three
male
three
femal
spf
cat
cell
anim
inocul
moi
h
pi
supernat
collect
tnfalpha
product
quantifi
antitnfalpha
captur
elisa
tnfalpha
untreat
cell
detect
limit
assay
b
pgml
observ
fipvinfect
pfbm
cell
suggest
anoth
cell
type
may
respons
product
cat
fip
time
mechan
mapk
regul
proinflammatori
cytokin
product
fipvinfect
pfbm
cell
unknown
howev
regul
cytokin
mapk
analog
system
occur
affect
either
transcript
regul
translat
regul
kumar
et
al
exampl
recent
emerg
sever
acut
respiratori
syndrom
coronaviru
sarscov
also
known
infiltr
immun
cell
monocyt
macrophag
activ
mapk
pathway
belyavski
et
al
frank
et
al
gu
et
al
nichol
et
al
sarscov
infect
caus
mapkdepend
phosphoryl
downstream
transcript
regul
activ
transcript
factor
signal
transduc
activ
transcript
well
translat
regul
mapk
activ
protein
kinas
eukaryot
initi
factor
mizutani
mizutani
et
al
mizutani
et
al
seen
fig
appear
fipv
caus
increas
mapk
nuclear
local
suggest
activ
transcript
factor
like
play
role
proinflammatori
product
pfbm
cell
howev
also
exclud
role
translat
regul
futur
studi
examin
role
downstream
transcript
translat
regul
fipvinfect
pfbm
cell
clarifi
mechan
regul
process
anoth
aspect
complic
treatment
fip
divers
reaction
infect
display
cat
diseas
kiss
et
al
result
suggest
activ
mapk
pathway
regul
tnfalpha
product
common
pfbm
cell
cat
howev
sampl
anim
throughout
differ
geograph
region
requir
confirm
conclus
pyridinyl
imidazol
compound
shown
efficaci
therapeut
agent
block
mediat
chronic
inflammatori
diseas
rheumatoid
arthriti
kumar
et
al
fact
sever
mapk
inhibitor
shown
promis
anim
model
inflammatori
diseas
even
reach
human
clinic
trial
kumar
et
al
result
show
clear
activ
mapk
fipv
infect
activ
respons
proinflammatori
cytokin
product
key
contributor
patholog
chang
observ
cat
fip
rais
possibl
mapk
inhibitor
alon
conjunct
therapi
may
possess
therapeut
benefit
treatment
cat
fip
primari
felin
bloodderiv
mononuclear
pfbm
cell
individu
purifi
four
male
spf
cat
anim
id
three
femal
spf
cat
anim
id
liberti
research
waverli
ny
use
standard
ficollpaqu
gradient
ge
healthcar
specifi
manufactur
cell
seed
plate
tissu
culturetr
glass
coverslip
allow
attach
overnight
wash
cell
incub
presenc
co
media
supplement
fetal
bovin
serum
fb
mm
glutamin
uml
penicillin
streptomycin
puriti
pfbm
prepar
routin
check
immunofluoresc
microscopi
use
marker
veterinari
medic
research
develop
inc
pullman
wa
crandellrees
felin
kidney
cell
obtain
american
type
cultur
collect
atcc
cultur
maintain
accord
atcc
guidelin
fipv
wsu
obtain
atcc
provid
dr
ed
dubovi
anim
health
diagnost
center
new
york
state
colleg
veterinari
medicin
cornel
univers
virus
grown
inocul
crfk
cell
moi
collect
supernat
cpe
observ
cell
typic
occur
h
supernat
fig
product
ill
beta
fipvinfect
pfbm
cell
pfbm
cell
pretreat
either
sb
sc
dmso
control
h
inocul
moi
h
pi
supernat
collect
beta
product
quantifi
beta
captur
elisa
clarifi
low
speed
centrifug
step
g
min
viral
particl
pellet
centrifug
rpm
rotor
sorval
min
pellet
resuspend
phosphatebuff
salin
pb
viru
titer
determin
plaqu
assay
crfk
cell
use
standard
techniqu
uvinactiv
thin
layer
viral
suspens
expos
uv
light
w
distanc
cm
min
inactiv
verifi
perform
infect
assay
crfk
pfbm
cell
describ
mapk
rabbit
monoclon
antibodi
mab
obtain
cell
signal
technolog
danver
mapk
goat
polyclon
antibodi
pab
antitnfalpha
goat
pab
obtain
santa
cruz
biotechnolog
santa
cruz
ca
antifipv
nucleocapsid
n
protein
mab
provid
dr
ed
dubovi
anim
health
diagnost
center
new
york
state
colleg
veterinari
medicin
cornel
univers
mab
obtain
veterinari
medic
research
develop
inc
pullman
wa
felin
tnfalpha
elisa
kit
felin
beta
elisa
kit
felin
elisa
kit
associ
antibodi
detect
reagent
obtain
r
system
minneapoli
mn
mapk
inhibitor
sb
pyrimidin
sc
obtain
calbiochem
san
diego
ca
pfbm
cell
incub
lowserum
media
fb
h
inocul
specifi
viru
moi
pretreat
specifi
inhibitor
h
follow
infect
mapk
activ
experi
cell
lyse
specifi
timepoint
lysi
buffer
triton
mm
trishcl
mm
nacl
mm
edta
mm
dtt
mm
betaglycerophosph
mm
sodium
vanad
ph
supplement
complet
proteas
inhibitor
cocktail
roch
lysat
clarifi
centrifug
rpm
tabletop
centrifug
min
freez
later
analysi
immunofluoresc
assay
cell
fix
specifi
timepoint
paraformaldehyd
analysi
cytokin
product
supernat
collect
h
postinocul
pi
freez
later
analysi
fix
cell
label
specifi
antibodi
describ
previous
chu
et
al
cell
view
nikon
eclips
fluoresc
microscop
imag
captur
sensicam
em
camera
analyz
iplab
softwar
sd
sampl
buffer
ad
lysat
reaction
heat
min
separ
use
sdspage
gel
v
h
gel
electroblot
pvdf
membran
h
block
bovin
serum
albumin
probe
specifi
antibodi
h
membran
develop
use
either
antirabbit
antibodi
southern
biotech
birmingham
al
antigoat
antibodi
santa
cruz
biotechnolog
santa
cruz
ca
link
horseradish
peroxidas
ecl
substrat
pierc
rockford
il
imag
captur
use
fujifilm
ccd
camera
western
blot
analysi
tnfalpha
product
supernat
concentr
use
icon
kda
molecular
weight
cutoff
spin
column
pierc
rockford
il
analyz
western
blot
describ
western
blot
densitometri
analysi
signal
intens
perform
use
imagej
softwar
quantif
cytokin
product
supernat
process
specifi
elisa
kit
r
system
use
standard
captur
elisa
techniqu
specifi
manufactur
